News

To find out if HIV infection increases the risk of skin cancer, investigators in Denmark designed a study comparing incidence and risk of BCC, SCC and MM among people in the national HIV cohort and ...
From the cancer registry, we identified primary cases of BCC, SCC and MM during the period of 1989–2003. We selected four population controls for each case from the Danish Civil Registration ...
The characteristics of cancer cases and controls are presented in Table 1.The median age was 68 years among BCC, 77 years among SCC, 58 years among MM, and 64 years among NHL cases.
Using the Danish Cancer Registry (DCR), the authors identified all cases of SCC, MM, and BCC diagnosed in individuals 20 years of age or older in northern Denmark from 1991 through 2009.
Sekulic A, Migden MR, Oro AE, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. ... Monroe MM. Cutaneous squamous cell carcinoma. Medscape. Updated April 7, 2014.
During the 16-year study period, 2,070 patients were diagnosed with at least one BCC, 1,364 with SCC, and 258 with MM. ASIRs were 28, 19, and 4 per 100,000 person-years for BCC, SCC, and melanoma, ...
To determine BCC's immune state, Demehri's research team studied a large collection of primary human BCCs compared to squamous cell carcinomas (SCCs), which have proven more responsive to immune ...
Negative biopsy margins of squamous cell carcinomas produced subsequent excisions free of residual tumor, while negative biopsy margins of basal cell carcinomas were not predictive in a recent study.
Patients treated with Erivedge for basal cell carcinoma had an increased risk for cutaneous squamous cell carcinomas, according to research published today in JAMA Dermatology.Researchers searched ...
Wehner MR, Linos E, Parvataneni R, Stuart SE, Boscardin WJ, Chren MM JAMA Dermatol. 2015;151:382-388. Study Summary. Keratinocyte carcinomas (KCs; basal cell carcinoma [BCC], squamous cell ...
Most often, skin cancer on the arm is a basal cell or squamous cell cancer or melanoma. Read about the symptoms, risk factors, prevention, and outlook.